Polypeptide Laboratories

Activities: Ingredients

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Finance

PolyPeptide Group appoints Dr Raymond De Vré as CEO

De Vré has previously worked in senior positions at Dr. Reddy’s Laboratories and McKinsey & Company
Manufacturing

Biotech chooses PolyPeptide Group for vaccine adjuvant intermediates

PolyPeptide Group has announced it will produce two key intermediates used in the production of Matrix-M, the adjuvant component of the vaccine used to enhance immune response and stimulate high levels of neutralising antibodies
Ingredients

Peptide producer NeoMPS expands facilities in France

<p>Peptide specialist NeoMPS, based in Strasbourg, France has started construction of a new 2400m<s type="sup">2</s> facility that will double the company's cGMP production capacity for late stage development and commercial scale peptide manufacturing.</p>
Subscribe now